Acute Brain Injuries
14
1
1
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Retrospective Study on Ventilator Weaning Outcomes in Patients With Acute Brain Injury
Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)
PK/PD Target Attainment of Ceftriaxone for the Prevention of Early Ventilator-associated Pneumonia in Neurologically Injured Patients
The Ketogenic Diet for Pediatric Acute Brain Injury
Risk Factors and Outcomes in Patients Treated in Neurocritical Care
Building Resiliency in Patients Admitted to the Neuroscience Intensive Care Unit and Their Caregivers
CONNECT-ME: Consciousness in Neurocritical Care Cohort Study Using fMRI and EEG
Vagus Nerve Stimulation to Treat Moderate Traumatic Brain Injury
Automated Measurement of Optic Nerve Sheath Diameter
A Multidimensional Inpatient Balance Training Class to Improve Functional Outcomes in Rehabilitation Inpatients With ABI
Effect of Increased Positive End-expiratory Pressure on Intracranial Pressure in Different Respiratory Mechanic in Acute Respiratory Distress Syndrome
Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury
Dexmedetomidine-based Sedation in Neurocritical Care Patients
Dynamic and Static Autoregulation After Brain Injury